Free Trial

Cytokinetics (CYTK) SEC Filings & 10K Form

$48.30
-0.68 (-1.39%)
(As of 05/24/2024 04:00 PM ET)

Recent Cytokinetics SEC Filings

DateFilerForm TypeView
05/22/2024
3:15 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:59 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:00 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:01 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:03 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:04 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:05 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:06 PM
COSTA SANTO J (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:17 PM
Bhanji Muna (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:00 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:05 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:37 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:30 PM
Cytokinetics (Issuer)
Lee Sung (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/25/2024
5:54 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:38 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:35 PM
Cytokinetics (Filer)
Form DEF 14A
04/08/2024
3:37 PM
Cytokinetics (Filer)
Form ARS
04/05/2024
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
5:57 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
6:02 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
6:07 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
5:52 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:26 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:50 AM
Cytokinetics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/06/2024
3:43 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:38 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
3:41 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
9:45 AM
Cytokinetics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/22/2024
4:19 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
1:03 PM
BlackRock Inc. (Filed by)
Cytokinetics (Subject)
Form SC 13G/A
01/19/2024
3:49 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
4:20 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
3:09 PM
Cytokinetics (Subject)
HENDERSON JOHN T (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
3:02 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
4:55 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:19 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2023
3:10 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2023
3:11 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
4:22 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
3:21 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Claim Your Complimentary Bitcoin Reward (Ad)

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now
11/03/2023
4:30 PM
Cytokinetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2023
3:48 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/19/2023
6:32 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
4:57 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:18 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/12/2023
5:39 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
3:22 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/06/2023
3:52 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:32 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
3:09 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2023
3:13 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
8:06 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
3:09 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
3:18 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:09 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:09 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2023
5:45 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:33 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2023
3:38 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/11/2023
4:32 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
4:18 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
3:14 PM
Cytokinetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2023
3:25 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/13/2023
6:24 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/13/2023
6:01 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/13/2023
3:09 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
3:10 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
4:12 PM
Bhanji Muna (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2023
3:17 PM
Bhanji Muna (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:18 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:19 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:20 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
1:18 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2023
4:49 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:50 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
4:47 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
3:31 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
4:06 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CYTK) was last updated on 5/27/2024 by MarketBeat.com Staff

From Our Partners